| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
and ERß, in Estrogen Target Tissues in Vivo through the Use of an ER
-Selective Ligand
Womens Health Research Institute (H.H.), Wyeth Research, Collegeville, Pennsylvania 19426; and Departments of Chemistry (J.A.K.) and Molecular and Integrative Physiology (B.S.K.), University of Illinois, Urbana, Illinois 61801
Address all correspondence and requests for reprints to: Dr. Benita S. Katzenellenbogen, Department of Molecular and Integrative Physiology, 524 Burrill Hall, 407 South Goodwin Avenue, University of Illinois, Urbana, Illinois 61801-3704. E-mail: katzenel{at}life.uiuc.edu.
Estrogens elicit many biomedically important responses in different target tissues, and the respective roles of the two estrogen receptors, ER
and ERß, in mediating these bioactivities is incompletely understood. In this study, we investigated the activity of an ER
-selective agonist ligand, propyl pyrazole triol (PPT), in several rat animal models to define the involvement of ER
in these biological responses. In a short-term (4 d) uterotrophic assay, PPT was found to be as efficacious as 17
-ethinyl-17ß-estradiol in stimulating uterine weight gain and up-regulating complement 3 gene expression. In a 6-wk chronic model, PPT completely prevented the ovariectomy-induced body weight increase and loss of bone mineral density. It also increased uterine weight and markedly reduced plasma cholesterol levels in these mature animals. PPT was also effective in the brain. It increased progesterone receptor mRNA in the arcuate and ventromedial nuclei of the hypothalamus and prevented experimentally induced hot flushes. Our findings indicate that several physiologically relevant estrogen-induced tissue responses can be effectively evoked via ER
alone. By providing an approach that is complementary to that of analyzing the phenotype and response of ER knockout animals, our findings also demonstrate that ER subtype-selective ligands can play a valuable role in enhancing our understanding of how estrogens work through the two ER subtypes.
This article has been cited by other articles:
![]() |
A. A. Kazi, K. H. Molitoris, and R. D. Koos Estrogen Rapidly Activates the PI3K/AKT Pathway and Hypoxia-Inducible Factor 1 and Induces Vascular Endothelial Growth Factor A Expression in Luminal Epithelial Cells of the Rat Uterus Biol Reprod, August 1, 2009; 81(2): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Braniste, M. Leveque, C. Buisson-Brenac, L. Bueno, J. Fioramonti, and E. Houdeau Oestradiol decreases colonic permeability through oestrogen receptor \#946;-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells J. Physiol., July 1, 2009; 587(13): 3317 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt Lung Cancer Risk in Relation to Dietary Acrylamide Intake J Natl Cancer Inst, May 6, 2009; 101(9): 651 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Lundholm, G Bryzgalova, H Gao, N Portwood, S Falt, K D Berndt, A Dicker, D Galuska, J R Zierath, J-A Gustafsson, et al. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms J. Endocrinol., November 1, 2008; 199(2): 275 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yokota, K. Oritani, K. P. Garrett, T. Kouro, M. Nishida, I. Takahashi, M. Ichii, Y. Satoh, P. W. Kincade, and Y. Kanakura Soluble Frizzled-Related Protein 1 Is Estrogen Inducible in Bone Marrow Stromal Cells and Suppresses the Earliest Events in Lymphopoiesis J. Immunol., November 1, 2008; 181(9): 6061 - 6072. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sirianni, A. Chimento, C. Ruggiero, A. De Luca, R. Lappano, S. Ando, M. Maggiolini, and V. Pezzi The Novel Estrogen Receptor, G Protein-Coupled Receptor 30, Mediates the Proliferative Effects Induced by 17{beta}-Estradiol on Mouse Spermatogonial GC-1 Cell Line Endocrinology, October 1, 2008; 149(10): 5043 - 5051. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mattsson, J. A Olsson, and B. Brunstrom Selective estrogen receptor {alpha} activation disrupts sex organ differentiation and induces expression of vitellogenin II and very low-density apolipoprotein II in Japanese quail embryos Reproduction, August 1, 2008; 136(2): 175 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Catley, M. A. Birrell, E. L. Hardaker, J. de Alba, S. Farrow, S. Haj-Yahia, and M. G. Belvisi Estrogen Receptor {beta}: Expression Profile and Possible Anti-Inflammatory Role in Disease J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 83 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Sinkevicius, J. E. Burdette, K. Woloszyn, S. C. Hewitt, K. Hamilton, S. L. Sugg, K. A. Temple, F. E. Wondisford, K. S. Korach, T. K. Woodruff, et al. An Estrogen Receptor-{alpha} Knock-In Mutation Provides Evidence of Ligand-Independent Signaling and Allows Modulation of Ligand-Induced Pathways in Vivo Endocrinology, June 1, 2008; 149(6): 2970 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Carroll and C. J. Pike Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice Endocrinology, May 1, 2008; 149(5): 2607 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Santollo, M. D. Wiley, and L. A. Eckel Acute activation of ER{alpha} decreases food intake, meal size, and body weight in ovariectomized rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2194 - R2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tiwari-Woodruff, L. B. J. Morales, R. Lee, and R. R. Voskuhl Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER){alpha} and ERbeta ligand treatment PNAS, September 11, 2007; 104(37): 14813 - 14818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Arreguin-Arevalo, T. L. Davis, and T. M. Nett Differential Modulation of Gonadotropin Secretion by Selective Estrogen Receptor 1 and Estrogen Receptor 2 Agonists in Ovariectomized Ewes Biol Reprod, August 1, 2007; 77(2): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stygar, B. Masironi, H. Eriksson, and L. Sahlin Studies on estrogen receptor (ER) {alpha} and {beta} responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists J. Endocrinol., July 1, 2007; 194(1): 101 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zheng, A. Kallio, and P. Harkonen Tamoxifen-Induced Rapid Death of MCF-7 Breast Cancer Cells Is Mediated via Extracellularly Signal-Regulated Kinase Signaling and Can Be Abrogated by Estrogen Endocrinology, June 1, 2007; 148(6): 2764 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Harris Estrogen Receptor-{beta}: Recent Lessons from in Vivo Studies Mol. Endocrinol., January 1, 2007; 21(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Sundar, V. Kerekatte, C. N. Equinozio, V. B. Doan, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol Selectively Uncouples Expression and Activity of Estrogen Receptor Subtypes in Human Breast Cancer Cells Mol. Endocrinol., December 1, 2006; 20(12): 3070 - 3082. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bowe, X. F. Li, J. Kinsey-Jones, A. Heyerick, S. Brain, S. Milligan, and K. O'Byrne The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes. J. Endocrinol., November 1, 2006; 191(2): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Galmiche, N. Richard, S. Corvaisier, and M.-L. Kottler The Expression of Aromatase in Gonadotropes Is Regulated by Estradiol and Gonadotropin-Releasing Hormone in a Manner that Differs from the Regulation of Luteinizing Hormone Endocrinology, September 1, 2006; 147(9): 4234 - 4244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Hsieh, S. S. Rajan, S. K. Sharma, Y. Guo, E. R. DeSombre, M. Mrksich, and G. L. Greene Identification of Ligands with Bicyclic Scaffolds Provides Insights into Mechanisms of Estrogen Receptor Subtype Selectivity J. Biol. Chem., June 30, 2006; 281(26): 17909 - 17919. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. J. Morales, K. K. Loo, H.-b. Liu, C. Peterson, S. Tiwari-Woodruff, and R. R. Voskuhl Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci., June 21, 2006; 26(25): 6823 - 6833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Warden, L. K. Saxon, A. B. Castillo, and C. H. Turner Knee ligament mechanical properties are not influenced by estrogen or its receptors Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1034 - E1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Christoffel, G Rimoldi, and W Wuttke Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment. J. Endocrinol., March 1, 2006; 188(3): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Lund, L. R. Hinds, and R. J. Handa The Androgen 5{alpha}-Dihydrotestosterone and Its Metabolite 5{alpha}-Androstan-3beta, 17beta-Diol Inhibit the Hypothalamo-Pituitary-Adrenal Response to Stress by Acting through Estrogen Receptor beta-Expressing Neurons in the Hypothalamus J. Neurosci., February 1, 2006; 26(5): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Follettie, M. Pinard, J. C. Keith Jr., L. Wang, D. Chelsky, C. Hayward, P. Kearney, P. Thibault, E. Paramithiotis, A. J. Dorner, et al. Organ Messenger Ribonucleic Acid and Plasma Proteome Changes in the Adjuvant-Induced Arthritis Model: Responses to Disease Induction and Therapy with the Estrogen Receptor-{beta} Selective Agonist ERB-041 Endocrinology, February 1, 2006; 147(2): 714 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bodo, A. E. Kudwa, and E. F. Rissman Both Estrogen Receptor-{alpha} and -{beta} Are Required for Sexual Differentiation of the Anteroventral Periventricular Area in Mice Endocrinology, January 1, 2006; 147(1): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kublickiene, E. Svedas, B.-M. Landgren, M. Crisby, N. Nahar, H. Nisell, and L. Poston Small Artery Endothelial Dysfunction in Postmenopausal Women: In Vitro Function, Morphology, and Modification by Estrogen and Selective Estrogen Receptor Modulators J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6113 - 6122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Komm, Y. P. Kharode, P. V. N. Bodine, H. A. Harris, C. P. Miller, and C. R. Lyttle Bazedoxifene Acetate: A Selective Estrogen Receptor Modulator with Improved Selectivity Endocrinology, September 1, 2005; 146(9): 3999 - 4008. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Schreihofer, K. D. Do, and A. M. Schreihofer High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R103 - R108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gingerich and T. L. Krukoff Estrogen Modulates Endothelial and Neuronal Nitric Oxide Synthase Expression via an Estrogen Receptor {beta}-Dependent Mechanism in Hypothalamic Slice Cultures Endocrinology, July 1, 2005; 146(7): 2933 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Miller, T. Jover, H. W. Cohen, R. S. Zukin, and A. M. Etgen Estrogen Can Act via Estrogen Receptor {alpha} and {beta} to Protect Hippocampal Neurons against Global Ischemia-Induced Cell Death Endocrinology, July 1, 2005; 146(7): 3070 - 3079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rai, A. Frolova, J. Frasor, A. E. Carpenter, and B. S. Katzenellenbogen Distinctive Actions of Membrane-Targeted Versus Nuclear Localized Estrogen Receptors in Breast Cancer Cells Mol. Endocrinol., June 1, 2005; 19(6): 1606 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M. Elloso, K. Phiel, R. A Henderson, H. A Harris, and S. J Adelman Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands J. Endocrinol., May 1, 2005; 185(2): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-S. Lee, H.-J. Kim, Y.-W. Jung, K.-C. Choi, and E.-B. Jeung Estrogen Receptor {alpha} Pathway Is Involved in the Regulation of Calbindin-D9k in the Uterus of Immature Rats Toxicol. Sci., April 1, 2005; 84(2): 270 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Krishnan, H. A. Bullock, B. C. Yaden, M. Liu, R. J. Barr, C. Montrose-Rafizadeh, K. Chen, J. A. Dodge, and H. U. Bryant The Nongenotropic Synthetic Ligand 4-Estren-3{alpha}17{beta}-diol Is a High-Affinity Genotropic Androgen Receptor Agonist Mol. Pharmacol., March 1, 2005; 67(3): 744 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Chadwick, S. Chippari, E. Matelan, L. Borges-Marcucci, A. M. Eckert, J. C. Keith Jr., L. M. Albert, Y. Leathurby, H. A. Harris, R. A. Bhat, et al. Identification of pathway-selective estrogen receptor ligands that inhibit NF-{kappa}B transcriptional activity PNAS, February 15, 2005; 102(7): 2543 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Lund, T. Rovis, W. C. J. Chung, and R. J. Handa Novel Actions of Estrogen Receptor-{beta} on Anxiety-Related Behaviors Endocrinology, February 1, 2005; 146(2): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Egan, J. A. Lawson, S. Fries, B. Koller, D. J. Rader, E. M. Smyth, and G. A. FitzGerald COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice Science, December 10, 2004; 306(5703): 1954 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaitseva, D. S. Yue, J. A. Katzenellenbogen, P. A. W. Rogers, and C. E. Gargett Estrogen Receptor-{alpha} Agonists Promote Angiogenesis in Human Myometrial Microvascular Endothelial Cells Reproductive Sciences, December 1, 2004; 11(8): 529 - 535. [Abstract] [PDF] |
||||
![]() |
V. M. Navarro, J. M. Castellano, R. Fernandez-Fernandez, M. L. Barreiro, J. Roa, J. E. Sanchez-Criado, E. Aguilar, C. Dieguez, L. Pinilla, and M. Tena-Sempere Developmental and Hormonally Regulated Messenger Ribonucleic Acid Expression of KiSS-1 and Its Putative Receptor, GPR54, in Rat Hypothalamus and Potent Luteinizing Hormone-Releasing Activity of KiSS-1 Peptide Endocrinology, October 1, 2004; 145(10): 4565 - 4574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.G.B. Hurst, D.W. Goad, M. Mohan, and J.R. Malayer Independent Downstream Gene Expression Profiles in the Presence of Estrogen Receptor {alpha} or {beta} Biol Reprod, October 1, 2004; 71(4): 1252 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.V.O. Carswell, I.M. Macrae, L. Gallagher, E. Harrop, and K.J. Horsburgh Neuroprotection by a selective estrogen receptor {beta} agonist in a mouse model of global ischemia Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1501 - H1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Lovegrove, J. Sun, K. A. Gould, D. B. Lubahn, K. S. Korach, and P. H. Lane Estrogen receptor {alpha}-mediated events promote sex-specific diabetic glomerular hypertrophy Am J Physiol Renal Physiol, September 1, 2004; 287(3): F586 - F591. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Carta and D. Sassoon Wnt7a Is a Suppressor of Cell Death in the Female Reproductive Tract and Is Required for Postnatal and Estrogen-Mediated Growth Biol Reprod, August 1, 2004; 71(2): 444 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-x. Zhang, D. C. Labaree, G. Mor, and R. B. Hochberg Estrogen to Antiestrogen with a Single Methylene Group Resulting in an Unusual Steroidal Selective Estrogen Receptor Modulator J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3527 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Unfer, M. L. Casini, L. Costabile, M. Mignosa, S. Gerli, and G. C. Di Renzo High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial Reproductive Sciences, July 1, 2004; 11(5): 323 - 328. [Abstract] [PDF] |
||||
![]() |
A. Hillisch, O. Peters, D. Kosemund, G. Muller, A. Walter, B. Schneider, G. Reddersen, W. Elger, and K.-H. Fritzemeier Dissecting Physiological Roles of Estrogen Receptor {alpha} and {beta} with Potent Selective Ligands from Structure-Based Design Mol. Endocrinol., July 1, 2004; 18(7): 1599 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stossi, D. H. Barnett, J. Frasor, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) {alpha} or ER{beta} in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors Endocrinology, July 1, 2004; 145(7): 3473 - 3486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Hawkins and P. Thomas The Unusual Binding Properties of the Third Distinct Teleost Estrogen Receptor Subtype ER{beta}a Are Accompanied by Highly Conserved Amino Acid Changes in the Ligand Binding Domain Endocrinology, June 1, 2004; 145(6): 2968 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barchiesi, E. K. Jackson, B. Imthurn, J. Fingerle, D. G. Gillespie, and R. K. Dubey Differential Regulation of Estrogen Receptor Subtypes {alpha} and {beta} in Human Aortic Smooth Muscle Cells by Oligonucleotides and Estradiol J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2373 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Iannone, C. A. Simmons, S. H. Kadwell, D. L. Svoboda, D. E. Vanderwall, S.-J. Deng, T. G. Consler, J. Shearin, J. G. Gray, and K. H. Pearce Correlation between in Vitro Peptide Binding Profiles and Cellular Activities for Estrogen Receptor-Modulating Compounds Mol. Endocrinol., May 1, 2004; 18(5): 1064 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hegele-Hartung, P. Siebel, O. Peters, D. Kosemund, G. Muller, A. Hillisch, A. Walter, J. Kraetzschmar, and K.-H. Fritzemeier Impact of isotype-selective estrogen receptor agonists on ovarian function PNAS, April 6, 2004; 101(14): 5129 - 5134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tena-Sempere, V.M. Navarro, A. Mayen, C. Bellido, and J.E. Sanchez-Criado Regulation of Estrogen Receptor (ER) Isoform Messenger RNA Expression by Different ER Ligands in Female Rat Pituitary Biol Reprod, March 1, 2004; 70(3): 671 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, A. Nagai, M.-A. Ikeda, and S. Hayashi Sexually Dimorphic and Estrogen-Dependent Expression of Estrogen Receptor {beta} in the Ventromedial Hypothalamus during Rat Postnatal Development Endocrinology, November 1, 2003; 144(11): 5098 - 5104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. McDonnell Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics Endocrinology, October 1, 2003; 144(10): 4237 - 4240. [Full Text] [PDF] |
||||
![]() |
H. A. Harris, L. M. Albert, Y. Leathurby, M. S. Malamas, R. E. Mewshaw, C. P. Miller, Y. P. Kharode, J. Marzolf, B. S. Komm, R. C. Winneker, et al. Evaluation of an Estrogen Receptor-{beta} Agonist in Animal Models of Human Disease Endocrinology, October 1, 2003; 144(10): 4241 - 4249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frasor, D. H. Barnett, J. M. Danes, R. Hess, A. F. Parlow, and B. S. Katzenellenbogen Response-Specific and Ligand Dose-Dependent Modulation of Estrogen Receptor (ER) {alpha} Activity by ER{beta} in the Uterus Endocrinology, July 1, 2003; 144(7): 3159 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, J. Baudry, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Molecular Basis for the Subtype Discrimination of the Estrogen Receptor-{beta}-Selective Ligand, Diarylpropionitrile Mol. Endocrinol., February 1, 2003; 17(2): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |